Beximco Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh, renowned for its wide-ranging production and distribution of various medications and healthcare solutions. The company plays a critical role in manufacturing generic pharmaceutical formulations and active pharmaceutical ingredients (APIs), serving both domestic markets and numerous international territories. Beximco Pharma is distinguished by its commitment to innovation and quality, housing state-of-the-art facilities that comply with international regulatory standards, including those of the United States FDA and European regulatory bodies. This enables the company to successfully cater to the high-demand sectors of healthcare, spanning therapeutic areas such as cardiovascular, respiratory, and diabetic care, amongst others. Established in 1976 and headquartered in Dhaka, Beximco Pharma contributes significantly to the healthcare industry, supporting public health initiatives and enhancing the accessibility of essential medications worldwide, thus playing a pivotal role in the pharmaceutical landscape.
Markedsdata leveret af TwelveData og Morningstar